Biocryst Pharmaceuticals (BCRX) Net Equity Issued and Repurchased (2010 - 2026)
Biocryst Pharmaceuticals' Net Equity Issued and Repurchased came in at $6.2 million for Q2 2026, up 81.3% from $3.42 million a year earlier but down 68.2% from the prior quarter.
Biocryst Pharmaceuticals (BCRX) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biocryst Pharmaceuticals reported Net Equity Issued and Repurchased of $28.99 million, up 296.5% year-over-year; for FY2025, it was $9.12 million, up 164.7% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -37.2% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $3.44 million in FY2024 (-58.7%), $8.34 million in FY2023 (-43.5%), $14.77 million in FY2022 (-70.5%) and $50 million in FY2021 (-46.4%).
- The five-year range for quarterly Net Equity Issued and Repurchased is -$586,000 (Q4 2024) to $37.75 million (Q4 2021).
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q1 2026 (growth of 715.0%), and the weakest in Q4 2023 (a decline of 99.0%).
- Business Quant data shows BCRX's Net Equity Issued and Repurchased at $19.48 million (Q1 2026), $657,000 (Q4 2025) and $2.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn | 6.20 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.20 Mn |
| Mar 31, 2026 | 19.48 Mn |
| Dec 31, 2025 | 657,000.00 |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 3.42 Mn |
| Mar 31, 2025 | 2.39 Mn |
| Dec 31, 2024 | -586,000.00 |
| Sep 30, 2024 | 2.09 Mn |
| Jun 30, 2024 | 264,000.00 |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 39,000.00 |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 5.08 Mn |
| Dec 31, 2022 | 4.01 Mn |
| Sep 30, 2022 | 3.25 Mn |
| Jun 30, 2022 | 147,000.00 |
| Mar 31, 2022 | 7.36 Mn |
| Dec 31, 2021 | 37.75 Mn |
| Sep 30, 2021 | 4.78 Mn |
Biocryst Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();